Enzyme inhibition as a possible cause of secondary increases in metabolite levels in patients with inborn errors of metabolism.
D000592:Amino Acid Metabolism, Inborn Errors / Q000209:etiology*; D000643:Ammonium Chloride / Q000494:pharmacology; D000645:Ammonium Sulfate / Q000494:pharmacology; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives*; D001123:Argininosuccinate Lyase / Q000037:antagonists & inhibitors*; D001124:Argininosuccinate Synthase / Q000037:antagonists & inhibitors*; D001125:Argininosuccinic Acid / Q000652:urine*; D002417:Cattle; D002956:Citrulline / Q000097:blood*; D008025:Ligases / Q000037:antagonists & inhibitors*; D008099:Liver / Q000201:enzymology; D008190:Lyases / Q000037:antagonists & inhibitors*; D008239:Lysine / Q000031:analogs & derivatives / Q000378:metabolism; D051381:Rats; D013552:Swine
D000643:Ammonium Chloride; D001125:Argininosuccinic Acid; D002956:Citrulline; D001120:Arginine; D008190:Lyases; D001123:Argininosuccinate Lyase; D008025:Ligases; D001124:Argininosuccinate Synthase; D008239:Lysine; D000645:Ammonium Sulfate; C100169:saccharopine